OncoZenge
@oncozenge.se
OncoZenge is developing a lozenge that will help millions of people with their oral pain. Our primary indication is oral mucositis, a painful side effect from radiotherapy and chemotherapy.
OncoZenge's Company Logos
OncoZenge's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#FF9700
Pizazz
255, 151, 0
36, 100, 50
0, 41, 100, 0
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#009392
Persian Green
0, 147, 146
180, 100, 29
100, 0, 1, 42
About OncoZenge
OncoZenge is a Swedish pharmaceutical company dedicated to improving the quality of life for patients suffering from oral pain caused by radiation therapy and chemotherapy for cancer. Their main focus is on developing a new treatment for effective pain relief. One of their leading products is BupiZenge, designed to address the severe side effect of cancer therapy known as oral mucositis (OM).
OM is characterized by painful sores and blisters in the mucous membranes of the mouth and throat, impacting the lives of millions of individuals worldwide. OncoZenge aims to alleviate this condition, which often leads to hospitalizations, difficulty eating, swallowing, and communicating. Clinical studies have shown that BupiZenge significantly reduces pain in the mouth and throat.
Founded in 2020 through a collaboration with leading clinicians, OncoZenge has a clear vision to enhance the well-being of patients experiencing oral pain, offering them improved comfort and a higher quality of life
